Inhibition of autolysosomes by repurposing drugs as a promising therapeutic strategy for the treatment of cancers
Autophagy process coordinates lysosomal destruction of cytoplasmic materials including damaged organelles and proteins. The double-membranous ‘autophagosome’ selectively sequesters the cytosolic components, followed by ‘autolysosome’ formation for degradation. By recycling energy, autophagy preserve...
Main Author: | Abdul Alim Al-Bari |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | All Life |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/26895293.2022.2078894 |
Similar Items
-
Molecular Mechanism of Autophagosome–Lysosome Fusion in Mammalian Cells
by: Po-Yuan Ke
Published: (2024-03-01) -
The Molecular Interplay between Human Coronaviruses and Autophagy
by: Ankit Shroff, et al.
Published: (2021-08-01) -
5-ALA localises to the autophagy compartment and increases its fluorescence upon autophagy enhancement through caloric restriction and spermidine treatment in human glioblastoma
by: Kim Fredericks, et al.
Published: (2024-03-01) -
Revisiting Rab7 Functions in Mammalian Autophagy: Rab7 Knockout Studies
by: Yoshihiko Kuchitsu, et al.
Published: (2018-11-01) -
Pharmacokinetic Profile of a Drug Repurposing Candidate for the Treatment of Cutaneous Leishmaniasis (in Silico)
by: Arlindo Gonzaga Branco Junior, et al.
Published: (2024-08-01)